Despite the striking similarities between RALA and RALB protein structure, overlapping GAP and GEF utilization, and a shared pool of downstream effectors, the RAL isoforms demonstrate unexpected disparity, even antagonism, of function in various cancers [5, 13]. The gene discussed is RALA; the disease is cancer.